The Source Blog
Trends in Price and Quality Transparency
All Payer Claims Databases (APCD)
For more on APCD’s, check out our Legislative Topics: All Payer Claims Databases overview on Medium.
-
Key:
- Mandatory, Existing
- Mandatory, Implementing
- Voluntary
- Private
Pharmaceutical Price Transparency Legislation
For more on this legislation, refer to our Issue Brief on The Source Blog and the NASHP Center for Rx Pricing.
-
Key:
- Price Transparency Legislation
Recent Action in Price and Quality Transparency
SB 1530 (see companion bill HB 3299) – Texas
Introduced: 2019 Status: Inactive / Dead
Relating to the applicability of mediation requirements for balance billing to certain health benefit plans.
HB 1903 (see companion bill SB 1852) – Texas
Introduced: 2019 Status: Inactive / Dead
Relating to disclosures required in connection with the issuance of certain health benefit plans.
SB 469 – Texas
Introduced: 2019 Status: Inactive / Dead
Relating to certain protected disclosures by pharmacists and pharmacies regarding amounts charged for prescription drugs.
HB 2041 – Texas
Introduced: 2019 Status: Enacted
House Bill 2041 amends the Health and Safety Code to require an independent freestanding emergency medical care facility and a hospital‑affiliated freestanding emergency medical care facility to provide to a patient or a patient’s legally …
HB 4137 – Texas
Introduced: 2019 Status: Inactive / Dead
Relating to the required notice of a patient’s right to receive an estimate of certain health care services provided by a physician.
SB 1742 (see companion bill HB 2630) – Texas
Introduced: 2019 Status: Enacted
Relating to physician and health care provider directories, preauthorization, utilization review, independent review, and peer review for certain health benefit plans and workers’ compensation coverage.
SB 1740 (see companion bill HB 2520) – Texas
Introduced: 2019 Status: Inactive / Dead
Relating to disclosures by certain health benefit plans to enrollees regarding certain preauthorized medical care and health care services.
Next | See all Legislation Records
Introduced: 2019 Status: Inactive / Dead
Relating to the applicability of mediation requirements for balance billing to certain health benefit plans.
HB 1903 (see companion bill SB 1852) – Texas
Introduced: 2019 Status: Inactive / Dead
Relating to disclosures required in connection with the issuance of certain health benefit plans.
SB 469 – Texas
Introduced: 2019 Status: Inactive / Dead
Relating to certain protected disclosures by pharmacists and pharmacies regarding amounts charged for prescription drugs.
HB 2041 – Texas
Introduced: 2019 Status: Enacted
House Bill 2041 amends the Health and Safety Code to require an independent freestanding emergency medical care facility and a hospital‑affiliated freestanding emergency medical care facility to provide to a patient or a patient’s legally …
HB 4137 – Texas
Introduced: 2019 Status: Inactive / Dead
Relating to the required notice of a patient’s right to receive an estimate of certain health care services provided by a physician.
SB 1742 (see companion bill HB 2630) – Texas
Introduced: 2019 Status: Enacted
Relating to physician and health care provider directories, preauthorization, utilization review, independent review, and peer review for certain health benefit plans and workers’ compensation coverage.
SB 1740 (see companion bill HB 2520) – Texas
Introduced: 2019 Status: Inactive / Dead
Relating to disclosures by certain health benefit plans to enrollees regarding certain preauthorized medical care and health care services.
Next | See all Legislation Records
Pharmaceutical Care Management v. Rutledge – Arkansas
District Court: Eastern District of Arkansas Status: Decided
The 8th Circuit held that both ERISA and Medicare Part D preempted Arkansas’ drug pricing law Act 900 (SB 688). Act 900 requires disclosure of …
PhRMA v. David – California
District Court: Eastern District of California Status: Pending
PhRMA is challenging California’s drug price transparency law SB 17 alleging that the law is unconstitutional because it violates the Commerce Clause, the First Amendment, …
Association for Accessible Medicines v. Frosh – Maryland
District Court: District of Maryland Status: Decided
In a significant victory for the pharmaceutical industry, the 4th U.S. Circuit Court of Appeals found Maryland’s landmark 2017 law (HB 631), which punishes generic …
PhRMA and BIO v. Sandoval – Nevada
District Court: District of Nevada Status: Decided
In September 2017, just three months after Nevada passed its insulin transparency law (SB 539) in June 2017 to increase transparency over the price of …
See all Litigation Records
District Court: Eastern District of Arkansas Status: Decided
The 8th Circuit held that both ERISA and Medicare Part D preempted Arkansas’ drug pricing law Act 900 (SB 688). Act 900 requires disclosure of …
PhRMA v. David – California
District Court: Eastern District of California Status: Pending
PhRMA is challenging California’s drug price transparency law SB 17 alleging that the law is unconstitutional because it violates the Commerce Clause, the First Amendment, …
Association for Accessible Medicines v. Frosh – Maryland
District Court: District of Maryland Status: Decided
In a significant victory for the pharmaceutical industry, the 4th U.S. Circuit Court of Appeals found Maryland’s landmark 2017 law (HB 631), which punishes generic …
PhRMA and BIO v. Sandoval – Nevada
District Court: District of Nevada Status: Decided
In September 2017, just three months after Nevada passed its insulin transparency law (SB 539) in June 2017 to increase transparency over the price of …
See all Litigation Records
News & Opinions
Articles & Reports
The Urban Institute
January 13, 2020
Health Affairs December 16, 2019
Global Health Journal December 5, 2019
USC-Brookings Schaeffer Initiative for Health Policy December 5, 2019
Health Affairs December 16, 2019
Global Health Journal December 5, 2019
USC-Brookings Schaeffer Initiative for Health Policy December 5, 2019
If you would like to report a possible data discrepancy, please email info@sourceonhealthcare.org or contact The Source here.